Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China.
Zhang R, Liu L, Zhou H, Chan EW, Li J, Fang Y, Li Y, Liao K, Chen S. · 2017
Read Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China. by Zhang R, Liu L, Zhou H, Chan EW, Li J, Fang Y, Li Y, Liao K, Chen S. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5440625.txt.
Introduction
Zhang and co-authors survey drug-resistant gut bacteria across hospitals in China. Their research article appeared in EBioMedicine. Carbapenems are reserve antibiotics for hard infections. Bacteria that resist them leave doctors few options. Such strains were spreading in Chinese hospitals. The team collected 1,105 resistant strains from 25 locales. They then read the genes behind the resistance.
Two carbapenemase genes explained 90 percent of cases. The gene blaKPC-2 covered 58 percent. The gene blaNDM covered 32 percent. A few clone types drove much of the spread. They include ST11 in Klebsiella pneumoniae. E. coli types ST131 and ST167 also stood out. The genes ride on plasmids that pass between bacteria. The NDM plasmids shared a tight common core. KPC plasmids were more varied. A fosfomycin resistance gene was common. The colistin resistance gene mcr-1 stayed rare.
Catalog record
| CREATOR | Zhang R, Liu L, Zhou H, Chan EW, Li J, Fang Y, Li Y, Liao K, Chen S. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China By Rong Zhang, Lizhang Liu, Hongwei Zhou, Edward Waichi Chan, Jiaping Li, Ying Fang, Yi Li, Kang Liao, Sheng Chen Published in: EBioMedicine DOI: 10.1016/j.ebiom.2017.04.032 ABSTRACT The increasing incidence of carbapenem-resistant Enterobacteriaceae (CRE) - mediated hospital infections in China prompted a need to investigate the genetic basis of emergence of such strains. A nationwide survey was conducted in China covering a total of 1105 CRE strains collected from 25 geographical locales with results showing that acquisition of two carbapenemase genes, blaKPC-2 and blaNDM, was responsible for phenotypic resistance in 90% of the CRE strains tested (58% and 32% respectively), among which several major strain types, such as ST11 of K. pneumoniae and ST131/ST167 of E. coli, were identified, suggesting that dissemination of specific resistant clones is mainly responsible for emergence of new CRE strains. Prevalence of the fosA3 gene which mediates fosfomycin resistance, was high, while the colistin resistance determinant mcr-1 was rarely present in these isolates. Consistently, the majority of the blaNDM-bearing plasmids recoverable from the test strains belonged to IncX3, which contained a common core structure, blaNDM-blaMBL-trpF. Likewise, the core structure of ISKpn27-blaKPC-2-ISKpn2 was observed among plasmids harboring the blaKPC-2 gene, although they were genetically more divergent. In conclusion, the increasing prevalence of CRE strains in China is attributed to dissemination of conservative mobile elements carrying blaNDM or blaKPC-2 on conjugative and non-conjugative plasmids. INTRODUCTION The scale of clinical and public health problems due to multidrug-resistant bacterial infections has further escalated in recent years following the emergence of blaNDM, a plasmid-borne carbapenem resistance gene that has been widely disseminated among various species of bacterial pathogens worldwide (Kumarasamy et al., 2010, Nordmann et al., 2012). Descriptions such as “superbug”, “nightmare bacteria” and “post-antibiotic era” reflected the seriousness of the antimicrobial resistance issue. Among the major multidrug-resistant organisms that emerged within the past two decades, carbapenem-resistant Enterobacteriaceae (CRE), which commonly cause untreatable and hard-to-treat infections among hospitalized patients, is considered an urgent threat according to a report by the Center for Diseases Control and Prevention (CDC) in 2013 on antibiotic resistance threats in the United States. In the past two decades, utilization of carbapenems such as imipenem and meropenem in clinical treatments has become necessary due to proliferation of multidrug-resistant bacterial pathogens in clinical settings (Zilberberg and Shorr, 2013, Goel et al., 2011). Such increase in carbapenem consumption has been accompanied by the emergence of carbapenem-resistant Gram-negative pathogens (Karaiskos and Giamarellou, 2014, Livermore, 2004, Livermore, 2009). According to the CDC report of 2013, > 9000 healthcare-associated infections are caused by CRE each year and almost half of the hospital patients who suffer from CRE-mediated bloodstream infections died subsequently (CDC, 2013). Each year, approximately 600 deaths result from infections caused by the two most common types of CRE, namely carbapenem-resistant Klebsiella spp. and E. coli (Yong et al., 2009). In China, the first clinical report of blaNDM involved carbapenem-resistant Acinetobacter baumannii strains detectable in four patients who resided in different provinces, in 2011 (Chen et al., 2011). Since then it has been recoverable in most species of Enterobacteriaceae, including K. pneumoniae, Klebsiella oxytoca, Escherichia coli, Enterobacter cloacae, Enterobacter aerogenes and Citrobacter freundii, in various cities or regions in China, such as Beijing, Changsha, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hebei, Hong Kong and Zhengzhou (Berrazeg et al., 2014, Qin et al., 2014). The first KPC producing CRE strain in China was reported in 2007, and the blaKPC-2 gene has since become the most widely spread carbapenemase gene in China as well as various parts of the world. In this study, we conducted a nationwide surveillance of the prevalence of CRE in China and investigated the molecular epidemiological features of these strains, and hoped to identify the key strains and mobile resistance elements responsible for causing an increase in prevalence of CRE-mediated infections in China. Findings of this work shall provide essential insight into development of effective strategies for worldwide control of CRE and reducing the rate of untreatable infections in clinical settings. MATERIALS AND METHODS Carbapenem-resistant Enterobacteriaceae Isolates Non-duplicated Enterobacteriaceae strains that exhibited carbapenem resistance phenotype (meropenem MIC ≥ 4 μg/ml) were collected from hospitals located in 25 Provinces and Municipalities in China, namely Anhui, Beijing, Fujian, Gansu, Guangdong, Guangxi, Guizhou, Hainan, Hebei, Henan, Hubei, Hunan, Jilin, Jiangxi, Liaoning, Nanjing, Shandong, Shanxi, Shaanxi, Shanghai, Sichuan, Tianjing, Xinjiang, Zhejiang and Chengdu, during the period, June 2014 through June 2015. One representative hospital (normally the largest general hospital in the location) from each location was chosen for sample collection. All strains were subjected to species confirmation using the Vitek 2 system (bioMérieux, Marcy-l'E' toile, France), and the MALDI-TOF MS apparatus (Bruker Microflex LT, Bruker Daltonik GmbH, Bremen, Germany). Antimicrobial Susceptibility Testing The minimal inhibitory concentrations (MICs) of 12 antibiotics, namely amoxicillin-clavulanic acid, cefotaxime, ceftazidime, imipenem, mropenem, amikacin, ciprofloxacin, colistin, fosfomycin and tigecycline, were determined using the agar dilution method, and the results were analyzed according to the CLSI criteria of 2016 (Huang et al., 2016, CLSI, 2016). The 2017 EUCAST breakpoints were used (available at http://www.eucast.org/clinical_breakpoints/) for tigecycline. Screening of Carbapenemase and Other Antimicrobial Resistance Genes PCR and nucleotide sequencing were performed to screen for the presence of the carbapenemase-encoding genes blaVIM, blaIMP, blaKPC, blaOXA-48 and blaNDM as described previously (Dallenne et al., 2010). Screening of fosA3 and mcr-1 was performed as previously described (Li et al., 2016, Li et al., 2017, Liu et al., 2017, Lin and Chen, 2015). An imipenem-EDTA double-disc synergy test and the modified Hodge test were used to assess the ability of the test strains to produce carbapenemases; analysis was performed according to CLSI guidelines (Huang et al., 2016, CLSI, 2016). PFGE and ST Typing Multi locus sequence typing (MLST) for these CRE isolates was performed according to the previously reported protocol (Liu et al., 2014). Clonal relationships of major ST stain types of K. pneumonia and E. coli were investigated by PFGE of XbaI-digested genomic DNA using a Rotaphor System 6.0 instrument (Whatman Biometra, Goettingen, Germany), with a running time of 24 h and pulse times of 3–40 s. Salmonella strain H9812 was used as the control strain. Dendrograms depicting the genetic relatedness of the test strains were generated from the homology matrix to describe the relationships of the PFGE profiles of the test strains. Conjugation, S1-PFGE and Southern Hybridization Conjugation experiments were carried out using the mixed broth method as previously described (Borgia et al., 2012). PFGE, S1-PFGE and Southern Hybridization were performed as previously described (Wang et al., 2015). Plasmid Sequencing Plasmids carrying the blaKPC-2 and blaNDM genes were extracted from transformants using the Plasmid Midi kits (Qiagen, Germany). The plasmids were subjected to sequencing using Illumina NextSeq 500 platforms. After obtaining the raw reads, SPAdes was utilized to perform the hybrid-assembly and obtain complete plasmid sequences. Illumina short-reads were then utilized to polish the finished plasmids. The RAST annotation pipeline was chosen to perform rapid annotation of the plasmids (Overbeek et al., 2014). Comparison of the plasmids against the highly homologous plasmids in the NCBI database was performed by BRIG (Alikhan et al., 2011). Plasmid Mapping PCR mapping of the conservative regions of IncX3 plasmid and regions carrying blaNDM-bearing mobile elements was performed on IncX3 plasmids